Results Healthcare

We engaged Results Healthcare because we knew they were the leading advisory house in the tech-enabled pharma services market. We were not disappointed - the level of insight they brought to our evaluation of the opportunity showed their in depth knowledge of this sector and we would definitely work with them again.

We highly recommend working with Results. We were impressed with their project management skills and insight into the health industry, and their hard work to help us achieve our goals in the sale of Health Unlimited US

We could not have achieved our expansion goals without Results Healthcare. Their expertise, relationships and intelligence helped position 2e for optimal value as we explored strategic options. They have been a critical part of our advisory team, and will continue to be key strategic partners for our business for years to come. The future of...

Results have been outstanding thoughout the process and I cannot recommend them highly enough! They are a smart team of genuine sector experts that are impressive with their craft and showed relentless commitment to delivering the best outcome possible. I am extremely happy with the team and the outcome they have achieved.

The team at Results Healthcare has many strong relationships with both the strategic and financial buyers in the Health Tech/Informatics sector. The advice we received was insightful throughout the entire process. We highly recommend them to anyone in our sector considering a strategic transaction as the next step for their business.

Results International were a pleasure to work with and provided excellent support - their deep healthtech and SaaS expertise combined with a well-honed ability to execute ensured an efficient process and a great result. We could not have done it without them!

We are delighted to announce that Results Healthcare acted as exclusive financial advisor to GHO Capital, on its acquisition, alongside management, of Sterling Pharma Solutions - a specialist in complex and difficult to manufacture active pharmaceutical ingredients (APIs).